Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing
NCT02163746 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2022-03-02
Summary
This study compares two well-known treatment options for Stage 2 hidradenitis suppurativa: carbon dioxide (CO2) laser excision versus surgical deroofing.
Conditions
Interventions
- PROCEDURE
-
CO2 (carbon dioxide) laser
- PROCEDURE
-
Surgical Deroofing
Sponsors & Collaborators
-
Henry Ford Health System
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 13 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-01-14
- Primary Completion
- 2015-12-20
- Completion
- 2016-06-07
Countries
- United States
Study Locations
More Related Trials
-
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
NCT07244263 ·Status: RECRUITING ·Phase: PHASE2
-
Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation
NCT06444087 ·Status: ACTIVE_NOT_RECRUITING
-
Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)
NCT06956235 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia
NCT06840470 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa
NCT07244510 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa
NCT06361836 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy
NCT05139602 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of the Immunomodulation in the Hidradenitis Suppurativa and Evaluation of a New Therapeutic Strategy
NCT05208099 ·Status: NOT_YET_RECRUITING
-
Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa
NCT07109765 ·Status: RECRUITING
-
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
NCT06993610 ·Status: RECRUITING ·Phase: PHASE2
-
Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
NCT06058520 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa
NCT06932003 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin
NCT05066113 ·Status: RECRUITING ·Phase: NA
-
Gentian Violet Treatment for Hidradenitis Suppurativa
NCT04388163 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Safety and Efficacy of Roflumilast Foam in HS
NCT07263230 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)
NCT05348681 ·Status: TERMINATED ·Phase: PHASE2
-
Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) Lesions
NCT04539886 ·Status: COMPLETED ·Phase: NA
-
Managed Access Programs for AIN457, Secukinumab
NCT05583604 ·Status: AVAILABLE
-
Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
NCT05093855 ·Status: COMPLETED ·Phase: PHASE2
-
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.
NCT05921994 ·Status: ACTIVE_NOT_RECRUITING
-
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
NCT07170917 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
NCT05103423 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Hidradenitis Suppurativa
NCT04856930 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa
NCT04989517 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)
NCT03713632 ·Status: COMPLETED ·Phase: PHASE3